DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity

Cellular senescence is a natural tumor suppression mechanism defined by a stable proliferation arrest. In the context of cancer treatment, cancer cell therapy-induced senescence (TIS) is emerging as an omnipresent cell fate decision that can be pharmacologically targeted at the molecular level to en...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Nicolas Malaquin, Arthur Vancayseele, Sophie Gilbert, Laureen Antenor-Habazac, Marc-Alexandre Olivier, Zakia Ait Ali Brahem, Fred Saad, Guila Delouya, Francis Rodier
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2020-07-01
סדרה:	Cells
נושאים:	prostate cancer cellular senescence senolytics PARP inhibitor enzalutamide
גישה מקוונת:	https://www.mdpi.com/2073-4409/9/7/1593
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!